The immune escape signature predicts the prognosis and immunotherapy sensitivity for pancreatic ductal adenocarcinoma

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest malignancies worldwide. Immune escape is considered to be a reason for immunotherapy failure in PDAC. In this study, we explored the correlation between immune escape-related genes and the prognosis of PDAC patients. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hao, Zheng, Li-Yan, Wu, Ling-Yan, Chen, Jun, Xu, Na, Mi, Sui-Cai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486201/
https://www.ncbi.nlm.nih.gov/pubmed/36147906
http://dx.doi.org/10.3389/fonc.2022.978921

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486201/
https://www.ncbi.nlm.nih.gov/pubmed/36147906
http://dx.doi.org/10.3389/fonc.2022.978921

Ejemplares similares